MedTrace Logo

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

NCT01880788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2015-09-18

No results posted yet for this study

Summary

The study will be designed as a case control evaluation to compare the genetic profiles of three groups of patients categorized according to diagnosis.

Group 1 - CNV secondary to CSC Group 2 - CSC without CNV Group 3 - CNV secondary to advanced AMD.

Conditions

  • Age Related Macular Degeneration
  • Choroidal Neovascularization
  • Central Serous Chorioretinopathy

Sponsors & Collaborators

  • Vitreous -Retina- Macula Consultants of New York

    collaborator OTHER

  • Sequenom, Inc.

    lead INDUSTRY

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-03-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01880788 on ClinicalTrials.gov